Cargando…

“Short agonist stop” protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study

INTRODUCTION: Poor responder patients remain a challenge in assisted reproductive technologies. The “short agonist stop” (SAS) stimulation protocol uses a double stimulation (flare up effect with the gonadotropin-releasing hormone (GnRH) agonist (GnRH-a) then gonadotropins) associated with a less st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mauries, Charlotte, Ranisavljevic, Noemie, Mollevi, Caroline, Brunet, Cecile, Hamamah, Samir, Brouillet, Sophie, Anahory, Tal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714551/ https://www.ncbi.nlm.nih.gov/pubmed/36465628 http://dx.doi.org/10.3389/fendo.2022.1056520

Ejemplares similares

Serum progesterone concentration on pregnancy test day might predict ongoing pregnancy after controlled ovarian stimulation and fresh embryo transfer
por: Duport Percier, Marie, et al.
Publicado: (2023)

Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing
por: du Boulet, Bertille, et al.
Publicado: (2022)

Biphasic (5–2%) oxygen concentration strategy significantly improves the usable blastocyst and cumulative live birth rates in in vitro fertilization
por: Brouillet, Sophie, et al.
Publicado: (2021)

Author Correction: Biphasic (5–2%) oxygen concentration strategy significantly improves the usable blastocyst and cumulative live birth rates in in vitro fertilization
por: Brouillet, Sophie, et al.
Publicado: (2022)

Molecular Characterization of a Rare Case of Monozygotic Dichorionic Diamniotic Twin Pregnancy after Single Blastocyst Transfer in Preimplantation Genetic Testing (PGT)
por: Brouillet, Sophie, et al.
Publicado: (2022)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

Low Luteal Serum Progesterone Levels Are Associated With Lower Ongoing Pregnancy and Live Birth Rates in ART: Systematic Review and Meta-Analyses
por: Ranisavljevic, Noemie, et al.
Publicado: (2022)

What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?
por: Blumenfeld, Zeev
Publicado: (2020)

Poor responders in in vitro fertilization (IVF) therapy: the challenge continues
por: Oehninger, S.
Publicado: (2011)

Development and Validation of a Clinical Pregnancy Failure Prediction Model for Poor Ovarian Responders During IVF/ICSI
por: Li, Fangyuan, et al.
Publicado: (2021)

Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes
por: Traver, Sabine, et al.
Publicado: (2015)

Future Fertility of Patients With No Embryo Transfer in Their First IVF Cycle Attempts
por: Zhu, Xuli, et al.
Publicado: (2022)

Fertility preservation in patients of childbearing age treated for breast cancer: A nationwide cohort study
por: Duraes, Martha, et al.
Publicado: (2022)

Management of Poor Responders in IVF: Is There Anything New?
por: Ubaldi, Filippo, et al.
Publicado: (2014)

Predicting IVF outcome in poor ovarian responders
por: Lebovitz, Oshrit, et al.
Publicado: (2022)

Endometrial microbiota profile in in-vitro fertilization (IVF) patients by culturomics-based analysis
por: Cariati, Federica, et al.
Publicado: (2023)

Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve
por: Hart, Roger J.
Publicado: (2019)

Impact of Women Obesity and Obesity Severity on Live Birth Rate after In Vitro Fertilization
por: Brunet, Cécile, et al.
Publicado: (2020)

ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation
por: Bercaire, Ludmila, et al.
Publicado: (2018)

Influence of sperm DNA fragmentation on the clinical outcome of in vitro fertilization-embryo transfer (IVF-ET)
por: Zhu, Chunhui, et al.
Publicado: (2022)

25(OH)VitD and human endocrine and functional fertility parameters in women undergoing IVF/ICSI
por: Tian, Mei, et al.
Publicado: (2022)

Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment
por: Abbara, Ali, et al.
Publicado: (2020)

Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis
por: Zhang, Jie, et al.
Publicado: (2023)

Self-Detection of the LH Surge in Urine After GnRH Agonist Trigger in IVF—How to Minimize Failure to Retrieve Oocytes
por: Cozzolino, Mauro, et al.
Publicado: (2020)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
por: Lv, Mu, et al.
Publicado: (2022)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
por: Chen, Qiuju, et al.
Publicado: (2019)

The Evolving Concept of Poor-Prognosis for Women Undertaking IVF and the Notion of Growth Hormone as an Adjuvant; A Single-Center Viewpoint
por: Yovich, John L., et al.
Publicado: (2019)

Development and validation of a live birth prediction model for expected poor ovarian response patients during IVF/ICSI
por: Gong, Xiaoyun, et al.
Publicado: (2023)

Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification
por: Grisendi, Valentina, et al.
Publicado: (2019)

Early stop of progesterone supplementation after confirmation of pregnancy in IVF/ICSI fresh embryo transfer cycles of poor responders does not affect pregnancy outcome
por: Pan, Song-Po, et al.
Publicado: (2018)

Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study
por: Lan, Jie, et al.
Publicado: (2021)

DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis
por: Keane, Kevin N., et al.
Publicado: (2018)

Molecular Signatures Correlated With Poor IVF Outcomes: Insights From the mRNA and lncRNA Expression of Endometriotic Granulosa Cells
por: Shi, Libing, et al.
Publicado: (2022)

Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders
por: Zhu, Jinliang, et al.
Publicado: (2020)

The earlier the initiation of gonadotropin in poor responders in luteal phase stimulation protocols, the better
por: Huang, Jia, et al.
Publicado: (2022)

Pregnancy outcome in delayed start antagonist versus microdose flare GnRH agonist protocol in poor responders undergoing IVF/ICSI: An RCT
por: Davar, Robab, et al.
Publicado: (2018)

Judging the Fertility Protective Effect of GnRH Agonists in Chemotherapy—It Is a Matter of Perspective
por: von Wolff, Michael, et al.
Publicado: (2017)

Decreased DNA Repair Ability: A Mechanism for Low Early Embryonic Development Potential of Oocytes From Overweight Patients After Fertilization in IVF Cycles
por: Li, Hui, et al.
Publicado: (2021)

SAT-225 Machine Leaning Models to Predict Personalized Response to Ovarian Stimulation during In Vitro Fertilization (IVF)
por: Jasuja, Angad, et al.
Publicado: (2019)

The Reproductive Outcome of Women with Hypogonadotropic Hypogonadism in IVF
por: Zhang, Chun-mei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n1vig901gmr5o3jb3ju9ns1esc